Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for acoramidis to a specific field?

Exact Matches

3
Related Substance Name

1
Display Name

1
Standardized Name

1
Any Name

Approximate Matches

3
Related Substance Name

2
Display Name

2
Standardized Name

2
Any Name

2
Reference Text / Citation

1
Note

There is one exact (name or code) match for acoramidis

ACORAMIDIS

T12B44A1OE

Search for Structure

Status:

US Approved Rx (2024)

Source:

NDA216540

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

First approved in 2024

Source:

NDA216540

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

Class (Stereo):

CHEMICAL (ACHIRAL)

Showing 1 - 3 of 3 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ACORAMIDIS

T12B44A1OE

Search for Structure

Status:

US Approved Rx (2024)

Source:

NDA216540

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

First approved in 2024

Source:

NDA216540

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

Class (Stereo):

CHEMICAL (ACHIRAL)

TRANSTHYRETIN V122I

C89QMA8W6P

Subunit 1 (127) Similarity Search Subunit 2 (127) Similarity Search Subunit 3 (127) Similarity Search Subunit 4 (127) Similarity Search

Sequence Search

Subunit 1 (127) Similarity Search Subunit 2 (127) Similarity Search Subunit 3 (127) Similarity Search Subunit 4 (127) Similarity Search

Status:

Other

Class:

PROTEIN

ACORAMIDIS HYDROCHLORIDE

VY9C88C2NV

Search for Structure

Status:

US Approved Rx (2024)

Source:

NDA216540

(2024)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

First approved in 2024

Source:

NDA216540

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216540

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of ACORAMIDIS

ACHIRAL

Protein

TRANSTHYRETIN V122I

Structure of ACORAMIDIS HYDROCHLORIDE

ACHIRAL

ACORAMIDIS HYDROCHLORIDE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1